Agios Pharmaceuticals reported $870.01M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amgen AMGN:US $ 19322M 802M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Astellas Pharma 4503:JP Y 989281M 65927M
AstraZeneca AZN:LN 20.92B 1.73B
Bayer BAYN:GR 39.55B 1.3B
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Exelixis EXEL:US $ 1851.64M 8.9M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Immunogen IMGN:US $ 373.87M 82.84M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Novartis NVS:US $ 38142M 906M
Novartis NOVN:VX 38.14B 906M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
YTE INCY:US $ 3625.84M 337.75M